Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg
4.5 (355) · $ 20.50 · In stock
The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.
MBAs Are Spurning Google to Buy Small Companies - Bloomberg
Novo Nordisk Sales Soar, Fortifying Grip on Obesity Drug Market - Bloomberg
One bad quarter for commodity prices won't hurt our company: Birchcliff Energy CEO - Video - BNN
Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer - BNN Bloomberg
Bulletin Daily Paper 08/13/12 by Western Communications, Inc. - Issuu
GO Slow: US Economic Growth Slumps in 2022 (But No Recession – Yet) - Gross Output
How Not to Negotiate a $6.1 Billion Deal - Bloomberg
Beyond Meat tops quarterly revenue estimates, plans 'steep' cost cuts in 2024
Where Bits and Bytes Meet Brick-and-Mortar Retail
Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg
In Pictures: The Richest People In The World
Novo Nordisk Sales Soar, Fortifying Grip on Obesity Drug Market - Bloomberg
